Canopy | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
OneCell Diagnostics Inc.
India
- Pune , Maharashtra
- 22/11/2024
- Series A
- $16,000,000
OneCell Diagnostics, Inc. is a Precision Oncology Liquid Biopsy Diagnostics Company focused on developing the 1st-in-Class, Circulating Tumor Cell (CTC)-based, Single-Cell Multi-omics Lab Developed Tests for applications in clinical cancer care & early-stage clinical trials for Biotech/Pharma companies.
OneCell Diagnostics, Inc. is a joint venture between two companies with innovative technologies: Actorius Innovations and Research Pvt Ltd, a leading provider of CTC Tests in India, and Indx.ai, a Silicon Valley based innovative software company specialising in Multi-omics Biomarker Data Analytics.
- Industry Biotechnology Research
- Website https://www.onecelldx.com/
- LinkedIn https://www.linkedin.com/company/onecelldx/
Related People
Mohan UttarwarCo Founder
United States -
Cupertino, California
* Serial entrepreneur who co-founded 5 companies, raised over $50M in investment and created the share-holder value of over $500M.
* Strategic thinker who can identify holes in the marketplace and attract a great team to build innovative products & solutions to fill those holes and get the first mover advantage.
* Visionary with a mission of touching the lives of 1B patients and making a societal impact around the world.
* Angel Investor with real world experience of helping entrepreneurs building business & creating value
Vizgen | $48,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)